CNS Pharmaceuticals (CNSP) said Wednesday it will implement a 1-for-50 reverse stock split to raise the company's per-share trading price and ensure compliance with Nasdaq's minimum share price listing requirement.
The company said its common stock will start trading on a split-adjusted basis on Nasdaq on Friday.
Shares of CNS Pharmaceuticals fell over 33% in recent trading.
Price: 0.10, Change: -0.05, Percent Change: -33.33
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.